Feb 7, 2024
Qure.ai, received breakthrough device designation from FDA, CDRH for its AI-powered Tuberculosis (TB) solution, qSpot-TB.
seen from Peru
seen from Ukraine
seen from Poland
seen from China
seen from United States
seen from United States
seen from Malaysia
seen from United States
seen from Ukraine
seen from Peru
seen from China
seen from Bangladesh
seen from Ukraine
seen from Guatemala
seen from Canada
seen from China
seen from China
seen from United States
seen from Ukraine
seen from China
Qure.ai, received breakthrough device designation from FDA, CDRH for its AI-powered Tuberculosis (TB) solution, qSpot-TB.
Qure.ai partners with Italy's San Raffaele Hospital - ETtech
Qure.ai partners with Italy’s San Raffaele Hospital – ETtech
[ad_1]
Image for representation only
Health tech startup Qure.ai has partnered with Italy’s San Raffaele Hospital to deploy new solutions that automatically read and interpret chest X-ray scans for Covid-19 in seconds.
The tool helps quantify how much of the patient’s lungs have been affected, thus enabling clinicians to monitor disease progression more effectively.
“By using our technology,…
View On WordPress